Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-23 3:05 pm Unchanged |
2024-09-30 | 13G | PolyPid Ltd. PYPD |
Rosalind Advisors, Inc. | 686,172 9.900% |
0 (Unchanged) |
Filing History |
| 2024-10-23 2:57 pm Purchase |
2024-09-30 | 13G | MediWound Ltd. MDWD |
Rosalind Advisors, Inc. | 628,050 5.800% |
114,560 (+22.31%) |
Filing History |
| 2024-10-23 2:44 pm Sale |
2024-09-30 | 13G | Trevi Therapeutics, Inc. TRVI |
Rosalind Advisors, Inc. | 750,000 1.030% |
-641,577 (-46.10%) |
Filing History |
| 2024-10-23 2:26 pm Sale |
2024-09-30 | 13G | Spruce Biosciences, Inc. SPRB |
Rosalind Advisors, Inc. | 0 0.000% |
-1,508,419 (Position Closed) |
Filing History |
| 2024-10-18 2:52 pm Purchase |
2024-09-30 | 13G | OptiNose, Inc. OPTN |
Rosalind Advisors, Inc. | 552,500 5.500% |
49,357 (+9.81%) |
Filing History |
| 2024-10-18 2:21 pm Unchanged |
2024-09-30 | 13G | Myomo, Inc. MYO |
Rosalind Advisors, Inc. | 4,575,385 9.900% |
0 (Unchanged) |
Filing History |
| 2024-08-14 7:20 pm Purchase |
2024-08-06 | 13G | PolyPid Ltd. PYPD |
Rosalind Advisors, Inc. | 686,172 9.900% |
686,172 (New Position) |
Filing History |
| 2024-08-14 7:15 pm Purchase |
2024-07-25 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors, Inc. | 6,970,425 9.900% |
2,977,839 (+74.58%) |
Filing History |
| 2024-07-12 10:35 am Unchanged |
2024-06-28 | 13G | Myomo, Inc. MYO |
Rosalind Advisors, Inc. | 4,575,385 9.900% |
0 (Unchanged) |
Filing History |
| 2024-07-11 6:02 pm Unchanged |
2024-06-28 | 13G | Myomo, Inc. MYO |
Rosalind Advisors, Inc. | 4,575,385 9.900% |
0 (Unchanged) |
Filing History |
| 2024-07-11 5:52 pm Purchase |
2024-06-28 | 13G | Trevi Therapeutics, Inc. TRVI |
Rosalind Advisors, Inc. | 1,391,577 1.980% |
465,561 (+50.28%) |
Filing History |
| 2024-07-11 5:48 pm Sale |
2024-06-28 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors, Inc. | 7,438,181 9.900% |
-21,747 (-0.29%) |
Filing History |
| 2024-07-11 5:43 pm Purchase |
2024-06-28 | 13G | MediWound Ltd. MDWD |
Rosalind Advisors, Inc. | 513,490 7.160% |
27,500 (+5.66%) |
Filing History |
| 2024-07-11 5:37 pm Unchanged |
2024-06-28 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors, Inc. | 3,992,586 9.900% |
0 (Unchanged) |
Filing History |
| 2024-05-29 3:47 pm Unchanged |
2024-03-28 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Rosalind Advisors, Inc. | 464,677 9.900% |
0 (Unchanged) |
Filing History |
| 2024-05-29 3:43 pm Purchase |
2024-03-28 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Rosalind Advisors, Inc. | 464,677 9.900% |
464,677 (New Position) |
Filing History |
| 2024-05-29 3:32 pm Purchase |
2024-05-10 | 13G | OptiNose, Inc. OPTN |
Rosalind Advisors, Inc. | 503,143 7.750% |
200,377 (+66.18%) |
Filing History |
| 2024-05-29 3:21 pm Purchase |
2024-05-13 | 13G | Biofrontera Inc. BFRI |
Rosalind Advisors, Inc. | 7,872,489 9.900% |
7,368,228 (+1461.19%) |
Filing History |
| 2024-05-17 12:58 pm Sale |
2024-04-24 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors, Inc. | 7,459,928 9.900% |
-1,528,390 (-17.00%) |
Filing History |
| 2024-05-17 12:48 pm Sale |
2024-04-18 | 13D | Delcath Systems, Inc. DCTH |
Rosalind Advisors, Inc. | 2,763,468 9.900% |
-188,734 (-6.39%) |
Filing History |